Alkermes plc (ALKS) Company Profile

ALKS Company Profile

Alkermes plc (ALKS) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. It trades on NASDAQ. The company is based in Ireland.

Alkermes plc, a mid-cap growth and value equity, is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathic hypersomnia. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio.

Market cap is $6.25B. There are 166.6M shares outstanding.

See the full Alkermes plc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if ALKS is a good investment.